Sloning, leading supplier of synthetic biology tools was awarded US Patent No, 7,695,906. Sloning’s

Nov. 5 – Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO)

September 30 -Bharat Biotech International (BBIL), a leading manufacturer of vaccines and biotherapeutics announced today its Anti-Staphylococcal Molecule

January 22 – Corbett, QIAGEN (QGEN), ltf Labortechnik GmbH & Co. KG, and Applied Biosystems, LLC, part of Life Technologies Corporation (Nasdaq: LIFE) today announced a settlement of their disputes concerning

October 2 – Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received final approval from the U.S.

September 6, Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food

Aug. 14 : Sigma-Aldrich , a leading $1.8 billion Life Science and High Technology company, has signed a national distribution agreement with CellPath, a leading distributor of healthcare products, to serve the healthcare market in the UK.

Aug. 14 : At the Board of Directors meeting held today, the Directors declared a quarterly cash dividend of $.115 per share. The dividend is payable on September 14, 2007 to shareholders of record on August 31, 2007.

Sigma-Aldrich Corporation , a leading Life Science and High Technology company with 2006 revenues of $1.8 billion, and Sangamo BioSciences, Inc. ,

SAFC, a member of the Sigma-Aldrich Group, announced today that it has completed the initial phase of a two-stage expansion at its SAFC Pharmorphix(TM) research facility in Cambridge, U.K., for its SAFC Pharma business. Completion of a 2,500 sq.